Letter to the Editor: Comment on 'Evaluating the Efficacy of Intratympanic Dexamethasone in Protecting Against Irreversible Hearing Loss in Patients on Cisplatin-Based Cancer Treatment: A Randomized Controlled Phase IIIB Clinical Trial' (Moreno and Belinchon 2022)

Autor:	Avi Shupak
Rok vydání:	2022
Předmět:	Speech and Hearing Injection Intratympanic Treatment Outcome Otorhinolaryngology Hearing Loss Sensorineural Neoplasms Humans Cisplatin Hearing Loss Sudden Hearing Loss Dexamethasone
Zdroj:	Ear and hearing. 43(3)
ISSN:	1538-4667
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::805a64b9a3d318eaa52746783afdaabd https://pubmed.ncbi.nlm.nih.gov/35298115 Zobrazit plný text záznamu